5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues
- PMID: 3950904
- DOI: 10.1021/jm00152a005
5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues
Abstract
1-(2,5-Dimethoxy-4-bromophenyl)-2-aminopropane (DOB; 1a) is a purported serotonin (5-HT) agonist that binds selectively to central 5-HT2 binding sites. Systematic removal of any or all of the aromatic substituents had relatively little effect on 5-HT1 binding but reduced 5-HT2 binding by approximately 2 or more orders of magnitude. Demethylation of the 2-methoxy group of 1a, or introduction of an N-n-propyl group, doubled 5-HT1-site affinity but decreased 5-HT2-site affinity by 3- and 30-fold, respectively. In tests of stimulus generalization, using rats trained to discriminate DOM from saline, the 2-demethyl and N-propyl derivatives were found to produce stimulus effects similar to those of DOB. In addition, the S-(+) isomer of the iodo analogue of 1a was found to possess one-third the affinity of its R-(-) enantiomer at 5-HT2 sites and also resulted in DOM-stimulus generalization. Of the DOB analogues examined, DOB (1a) possesses optimal selectivity for 5-HT2 binding.
Similar articles
-
N-methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.J Med Chem. 1987 May;30(5):930-2. doi: 10.1021/jm00388a032. J Med Chem. 1987. PMID: 3572981
-
5-HT1 and 5-HT2 binding characteristics of some quipazine analogues.J Med Chem. 1986 Nov;29(11):2375-80. doi: 10.1021/jm00161a038. J Med Chem. 1986. PMID: 3783595
-
Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.J Med Chem. 1992 Feb 21;35(4):734-40. doi: 10.1021/jm00082a014. J Med Chem. 1992. PMID: 1542100
-
A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.Pharmacol Biochem Behav. 1988 Jul;30(3):597-601. doi: 10.1016/0091-3057(88)90071-8. Pharmacol Biochem Behav. 1988. PMID: 3211969
-
Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.NIDA Res Monogr. 1989;94:240-58. NIDA Res Monogr. 1989. PMID: 2514364 Review.
Cited by
-
The behavioral pharmacology of hallucinogens.Biochem Pharmacol. 2008 Jan 1;75(1):17-33. doi: 10.1016/j.bcp.2007.07.018. Epub 2007 Jul 20. Biochem Pharmacol. 2008. PMID: 17977517 Free PMC article. Review.
-
Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts.Br J Pharmacol. 1989 Oct;98 Suppl(Suppl):606P-773P. Br J Pharmacol. 1989. PMID: 2775936 Free PMC article. No abstract available.
-
Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.Psychopharmacology (Berl). 1991;105(1):69-76. doi: 10.1007/BF02316866. Psychopharmacology (Berl). 1991. PMID: 1745714
-
Effect of Hallucinogens on Unconditioned Behavior.Curr Top Behav Neurosci. 2018;36:159-199. doi: 10.1007/7854_2016_466. Curr Top Behav Neurosci. 2018. PMID: 28224459 Free PMC article. Review.
-
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.Curr Top Behav Neurosci. 2017;32:283-311. doi: 10.1007/7854_2016_64. Curr Top Behav Neurosci. 2017. PMID: 28097528 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Chemical Information